angiodynamics initiates recover-av clinical trial assessing alphavac f18⁸⁵ system in treatment of pulmonary embolism and long-term functional outcomes
LATHAM, N.Y.--(BUSINESS WIRE)--AngioDynamics, Inc. (NASDAQ: ANGO), a leading and transformative medical technology company focused on restoring healthy blood flow in...